![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
Australia
0
South Africa
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
Details:
Data for Prothione (Glutathione) capsules, show that patients assigned treatment with the drug had a reduction in time to clinical resolution as defined by time to attain 3 consecutive negative RT-PCR tests and a statistically significant decrease in viral load of COVID-19.
Lead Product(s): L-Glutamic Acid,L-Cysteine,Glycine
Therapeutic Area: Infections and Infectious Diseases Product Name: Prothione
Highest Development Status: Phase II/ Phase IIIProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 15, 2022